HHS Continues to Oppose Unapproved Drugmaker 340B Rebate Models in New Legal Filings
The U.S. Department of Health and Human Services (HHS) is continuing its pushback against drugmaker attempts to unilaterally convert upfront [...]
*Sign up for news summaries and alerts from 340B Report